Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Market Cap

Tianjin Pharmaceutical Da Ren Tang Group Corporation has a market cap or net worth of 22.41 billion as of November 21, 2024. Its market cap has increased by 12.29% in one year.

• Market Cap: 22.41B
• Enterprise Value: 22.23B
• Revenue: 8.04B
• Ranking: n/a
• PE Ratio: 27.78
• Stock Price: 33.90

Market Cap Chart

Since June 6, 2001, Tianjin Pharmaceutical Da Ren Tang Group Corporation's market cap has increased from 6.92B to 22.41B, an increase of 224.05%. That is a compound annual growth rate of 5.14%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	22.55B	1.92%
Dec 29, 2023	22.12B	21.24%
Dec 30, 2022	18.25B	-6.30%
Dec 31, 2021	19.47B	73.88%
Dec 31, 2020	11.20B	23.50%
Dec 31, 2019	9.07B	9.70%